Breast Neoplasms: all 12,820 studies

Page 45 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Phase II Study of AZD2281 in Patients With Known BRCA Mutation Status or Recurrent High Grade Ovarian Cancer or Patients With Known BRCA Mutation Status/ Triple Neg Breast CancerCompletedNCT00679783Phase 2Results posted
• A Study of the Efficacy and Safety of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) vs. Trastuzumab (Herceptin®) and Docetaxel (Taxotere®) in Patients With Metastatic HER2-positive Breast Cancer Who Have Not Received Prior Chemotherapy for Metastatic DiseaseCompletedNCT00679341Phase 2Results posted
• A Study of Trastuzumab-Mcc-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast CancerCompletedNCT00679211Phase 2Results posted
• Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast CancerTerminatedNCT00679029Phase 2Results posted
• A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer ProgressionCompletedNCT00676793Phase 2Results posted
• Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast CancerCompletedNCT00676663Phase 2Results posted
• Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast CancerCompletedNCT00675259Phase 2Results posted
• A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast CancerTerminatedNCT00674206Phase 2Results posted
• Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and MelanomaCompletedNCT00671918Phase 3Results posted
• Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast CancerCompletedNCT00670982Phase 2Results posted
• Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast CancerCompletedNCT00667251Phase 3Results posted
• Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by SurgeryTerminatedNCT00665457Phase 2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerCompletedNCT00662129Phase 2Results posted
• Study Of Sunitinib With Capecitabine In Breast CancerCompletedNCT00662025Phase 2Results posted
• Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine TherapyTerminatedNCT00661531Phase 2Results posted
• Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02CompletedNCT00659373Phase 3Results posted
• Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast CancerCompletedNCT00656669Not applicableResults posted
• Development of Vitamin D as a Therapy for Breast Cancer - Phase 2CompletedNCT00656019Phase 2Results posted
• Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT00654836Phase 2Results posted
• Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast CancerCompletedNCT00645333Phase 1/2Results posted
• Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)TerminatedNCT00638963Phase 2Results posted
• Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast CancerTerminatedNCT00636441Phase 2Results posted
• Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With AvastinCompletedNCT00635050Phase 2Results posted
• Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast CancerCompletedNCT00634634Phase 1/2Results posted
• Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerTerminatedNCT00634088Phase 1Results posted
• Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by SurgeryCompletedNCT00633750Phase 2Results posted
• Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast CancerCompletedNCT00633464Phase 2Results posted
• A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast CancerTerminatedNCT00632541Phase 2Results posted
• LBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer PatientsCompletedNCT00632489Phase 1Results posted
• A Phase II Biomarker Trial of Gelatin Encapsulated Extract of American Ginseng Root (LEAG) in Breast CancerCompletedNCT00631852Phase 2Results posted
• Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast TumorsTerminatedNCT00630292Not applicableResults posted
• Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast CancerCompletedNCT00630032Phase 3Results posted
• Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast CancerCompletedNCT00629499Phase 2Results posted
• Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of NeuronsCompletedNCT00627978Phase 2Results posted
• QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast CancerCompletedNCT00626106Phase 2Results posted
• Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast CancerCompletedNCT00623233Phase 2Results posted
• Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast CancerTerminatedNCT00622466Phase 2Results posted
• Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12TerminatedNCT00622401Phase 1/2Results posted
• Molecular Breast Imaging as a Screening Tool for Women With Dense BreastsCompletedNCT00620373Not applicableResults posted
• A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast CancerCompletedNCT00618826Phase 2Results posted
• Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant SettingCompletedNCT00618657Phase 2Results posted
• Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast CancerCompletedNCT00617942Phase 2Results posted
• Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain MetastasesCompletedNCT00617539Phase 2Results posted
• Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast CancerActive, not recruitingNCT00616967Phase 2Results posted
• Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast CancerTerminatedNCT00616122Phase 1/2Results posted
• Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast CancerCompletedNCT00615901Not applicableResults posted
• Proton Therapy for Early Stage Breast CancerCompletedNCT00614172Not applicableResults posted
• Flaxseed, Aromatase Inhibitors and Breast Tumor CharacteristicsCompletedNCT00612560Not applicableResults posted
• Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer.TerminatedNCT00611715Phase 2Results posted
• Mammosite Breast Brachytherapy Optimization in the Treatment of Breast CarcinomaCompletedNCT00611624Not applicableResults posted
• Combined MRI and Optical Imaging to Improved Breast Cancer DiagnosisTerminatedNCT00610467Not applicableResults posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast CancerActive, not recruitingNCT00609791Phase 2Results posted
• Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast CancerCompletedNCT00608972Phase 2Results posted
• Pilot Study to Evaluate High Resolution PET Image-Guidance for Sampling of Breast AbnormalitiesCompletedNCT00606931Not applicableResults posted
• Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal TreatmentCompletedNCT00605267Phase 3Results posted
• Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)TerminatedNCT00604968Phase 4Results posted
• Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast CancerTerminatedNCT00603408Phase 2Results posted
• F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast CancerCompletedNCT00602043Phase 2Results posted
• Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast CancerCompletedNCT00601900Phase 3Results posted
• 2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus BevacizumabCompletedNCT00600340Phase 3Results posted
• Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast CancerTerminatedNCT00597597Phase 2Results posted
• Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast CancerCompletedNCT00593827Phase 2Results posted
• Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic EvaluationCompletedNCT00591864Not applicableResults posted
• Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: FeasibilityCompletedNCT00591851Phase 2Results posted
• Evaluation of Breast CTCompletedNCT00584233Not applicableResults posted
• A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With CancerTerminatedNCT00584012Phase 1Results posted
• Partial Breast Irradiation Using Accelerated Intensity Modulated RadiotherapyTerminatedNCT00581529Phase 2Results posted
• A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast CancerCompletedNCT00581256Phase 1/2Results posted
• Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast CancerCompletedNCT00580333Phase 2Results posted
• Study of Breast Cancer Prevention by Letrozole in High Risk WomenCompletedNCT00579826Phase 2Results posted
• Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast CancerCompletedNCT00577122Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer.TerminatedNCT00576901Phase 2Results posted
• Trial for Locally Advanced Breast Cancer Using Vorinostat Plus ChemotherapyCompletedNCT00574587Phase 1/2Results posted
• Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast CancerTerminatedNCT00574236Phase 2Results posted
• Healing Touch in Treating Fatigue in Women Undergoing Radiation Therapy for Breast CancerCompletedNCT00574145Not applicableResults posted
• Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast CancerTerminatedNCT00573755Phase 2Results posted
• Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast CancerCompletedNCT00572728Phase 2Results posted
• Pilot Study of Radiofrequency Ablation of Breast Cancer Lumpectomy Sites to Decrease Re-operationCompletedNCT00571987Phase 1/2Results posted
• Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor FailureCompletedNCT00570921Phase 2Results posted
• Brain Mets - Capecitabine Plus Sunitinib and WBRTTerminatedNCT00570908Phase 2Results posted
• Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast CancerCompletedNCT00570323Phase 2Results posted
• Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal TherapyTerminatedNCT00570258Phase 2Results posted
• A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast CancerCompletedNCT00568022Phase 1Results posted
• A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer (MBC) Whose Disease Has Progressed on or After TrastuzumabTerminatedNCT00567879Phase 1/2Results posted
• A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast CancerCompletedNCT00567190Phase 3Results posted
• Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone MetastasisCompletedNCT00566618Phase 1/2Results posted
• Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After SurgeryCompletedNCT00562718Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast CancerCompletedNCT00559845Phase 2Results posted
• A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer.CompletedNCT00559754Phase 2Results posted
• Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By SurgeryCompletedNCT00559507Phase 2Results posted
• Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone DiseaseCompletedNCT00558272Phase 2Results posted
• Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast CancerCompletedNCT00558103Phase 2Results posted
• Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the BreastTerminatedNCT00556907Not applicableResults posted
• Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor TherapyCompletedNCT00556374Phase 3Results posted
• Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian FailureTerminatedNCT00555477Phase 2Results posted
• Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In SituCompletedNCT00555152Not applicableResults posted
• Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast CancerCompletedNCT00553410Phase 3Results posted
• Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) StudyCompletedNCT00553358Phase 3Results posted
• Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048)CompletedNCT00550771Phase 2Results posted
• Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast CancerTerminatedNCT00549822Phase 2Results posted

← Breast Neoplasms overview